ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 87 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,749 | +35.9% | 43,749 | +47.9% | 0.00% | – |
| Q2 2023 | $47,632 | -48.4% | 29,585 | -7.0% | 0.00% | – |
| Q1 2023 | $92,298 | +96.7% | 31,827 | +122.5% | 0.00% | – |
| Q4 2022 | $46,924 | -23.1% | 14,306 | -10.8% | 0.00% | – |
| Q3 2022 | $61,000 | -24.7% | 16,045 | +53.5% | 0.00% | – |
| Q2 2022 | $81,000 | -27.7% | 10,456 | -13.2% | 0.00% | – |
| Q1 2022 | $112,000 | +55.6% | 12,045 | +513.3% | 0.00% | – |
| Q2 2018 | $72,000 | +9.1% | 1,964 | +15.5% | 0.00% | – |
| Q1 2018 | $66,000 | +266.7% | 1,701 | +68.2% | 0.00% | – |
| Q4 2017 | $18,000 | -25.0% | 1,011 | -30.5% | 0.00% | – |
| Q3 2017 | $24,000 | +26.3% | 1,454 | +5.7% | 0.00% | – |
| Q2 2017 | $19,000 | -34.5% | 1,376 | -2.1% | 0.00% | – |
| Q1 2017 | $29,000 | +52.6% | 1,405 | +7.1% | 0.00% | – |
| Q4 2016 | $19,000 | – | 1,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |